ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 149 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $314,955 | -10.9% | 12,327 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $353,538 | +19.6% | 12,327 | 0.0% | 0.00% | +50.0% |
| Q1 2023 | $295,479 | +41.3% | 12,327 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $209,066 | +14.4% | 12,327 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $182,686 | -5.8% | 12,327 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $194,027 | -41.6% | 12,327 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $332,336 | +21.1% | 12,327 | +66.3% | 0.00% | 0.0% |
| Q4 2021 | $274,318 | -22.5% | 7,412 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $354,145 | +17.1% | 7,412 | -17.1% | 0.00% | 0.0% |
| Q2 2021 | $302,496 | -18.1% | 8,939 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $369,181 | -4.8% | 8,939 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $387,774 | +27.6% | 8,939 | +26.2% | 0.00% | +33.3% |
| Q3 2020 | $303,904 | +7.6% | 7,084 | +17.2% | 0.00% | 0.0% |
| Q2 2020 | $282,497 | – | 6,044 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |